Clinical trial

Access to Genetic Testing in Underserved Patients With Cancer

NCT06422455

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2023-10-24

PhaseNA

Study timeline

Study start (actual)2023-10-24Date precision: day

Registry last updated2026-03-18

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Breast Carcinomaunresolved

Male Breast Carcinomaunresolved

Malignant Solid Neoplasmunresolved

Metastatic Prostate Carcinomaunresolved

Ovarian Carcinomaunresolved

Pancreatic Exocrine Neoplasmunresolved

Stage IVB Prostate Cancer American Joint Committee on Cancer v8unresolved

Triple-Negative Breast Carcinomaunresolved

Interventions

Best PracticeOTHER

Educational InterventionOTHER

Electronic Health Record ReviewOTHER

Genetic CounselingOTHER

Survey AdministrationOTHER

Sponsors & collaborators

University of Southern Californialead sponsor

National Cancer Institute (NCI)collaborator

Northeastern Universitycollaborator

Dana-Farber Cancer Institutecollaborator

Mapped research locations

Los AngelesCalifornia, United States1 RochesterNew York, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06422455 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.